Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors
Open Access
- 27 February 2024
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 22 (3) , 110
Abstract
α-Conotoxins (α-CTxs) are structurally related peptides that antagonize nicotinic acetylcholine receptors (nAChRs), which may serve as new alternatives to opioid-based treatment for pain-related conditions. The non-natural amino acid analogues of α-CTxs have been demonstrated with improved potency compared to the native peptide. In this study, we chemically synthesized Dab/Dap-substituted analogues of α-CTx PeIA and evaluated their activity at heterologously expressed human α9α10 nAChRs. PeIA[S4Dap, S9Dap] had the most potent half-maximal inhibitory concentration (IC50) of 0.93 nM. Molecular dynamic simulations suggested that the side chain amino group of Dap4 formed additional hydrogen bonds with S168 and D169 of the receptor and Dap9 formed an extra hydrogen bond interaction with Q34, which is distinctive to PeIA. Overall, our findings provide new insights into further development of more potent analogues of α-CTxs, and PeIA[S4Dap, S9Dap] has potential as a drug candidate for the treatment of chronic neuropathic pain.Keywords
Funding Information
- National Natural Science Foundation of China (32171267, 82122064, APP2014544, 2022QNLM030003-4, 2022CXGC020414)
- National Health and Medical Research Council (32171267, 82122064, APP2014544, 2022QNLM030003-4, 2022CXGC020414)
- Qingdao National Laboratory for Marine Science and Technology (32171267, 82122064, APP2014544, 2022QNLM030003-4, 2022CXGC020414)
- Shandong Major Innovation Project (32171267, 82122064, APP2014544, 2022QNLM030003-4, 2022CXGC020414)
This publication has 29 references indexed in Scilit:
- Activation of alpha7 acetylcholine receptors reduces neuropathic pain by decreasing dynorphin A release from microgliaBrain Research, 2019
- α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptorsNeuroscience Letters, 2018
- Nicotinic acetylcholine receptors in neuropathic and inflammatory painFEBS Letters, 2017
- The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatmentExperimental Neurology, 2016
- α-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangementPain, 2014
- Effects of alpha 7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain modelsNeuropharmacology, 2013
- Nicotinic acetylcholine receptors: From basic science to therapeuticsPharmacology & Therapeutics, 2013
- Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammationNeurochemistry International, 2012
- Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic painNeuropharmacology, 2012
- Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neuronesBrain Research, 2005